Stock Liao information

— Basic knowledge of stocks|Introduction to basics of stocks|Stock learning|Basic knowledge of stocks
Mobile access:m.liaochihuo.com

Chinese stock market: The rise of the traditional Chinese medicine sector, these 19 leading stocks dominate the market (list)

Release Time:2022-05-28 Topic:Top 10 leading pharmaceutical stocks Reading:93 Navigation:Stock Liao information > Health regimen > traditional Chinese medicine > Chinese stock market: The rise of the traditional Chinese medicine sector, these 19 leading stocks dominate the market (list) phone-reading

Taiji Group

The highest number of closed orders: 6,766,000, the current number of closed plates: 4,672,800, accounting for 1.30% of the actual circulation, accounting for the transaction on the day Amount: 22.57%.

Taiji Group's daily limit is classified as traditional Chinese medicine + pension + medical beauty

1. The company takes Chinese and Western patent medicine manufacturing as its core business , has a complete pharmaceutical industry chain such as pharmaceutical industry, pharmaceutical business, and medicinal material planting. With 13 pharmaceutical factories and more than 30 pharmaceutical commercial companies, it is a large-scale pharmaceutical group integrating "industry, commerce, science and trade" and one of the most complete large-scale enterprise groups in the domestic pharmaceutical industry chain.

2. The company makes use of the existing land advantages of Changshou Lake Taiji Island in Chongqing, Wuling Mountain National Forest Park, and Hainan Tunchang to lay out the health care industry and build a four-season health care base.

3. The company holds a 15.65% stake in Chengdu Traditional Chinese Medicine Da Yinhai Eye Hospital Co., Ltd., and is the second largest shareholder of Yinhai Eye Hospital. Chengdu Yinhai Eye Hospital of Traditional Chinese Medicine is a comprehensive medical aesthetic center featuring ophthalmic full-eye plastic surgery, integrating medical aesthetic clinical diagnosis and treatment, scientific research and teaching, and academic exchanges.

China Resources Sanjiu

The highest number of closed orders: 7.6474 million, the current number of closed plates: 3.5901 million, accounting for 1.01% of the actual circulation, accounting for Volume of the day: 21.47%.

The reason for the daily limit of China Resources Sanjiu is traditional Chinese medicine + mask

1. The company is mainly engaged in the research and development, production of pharmaceutical products, Sales and related health services. The main products include 999 Ganmaoling, 999 Piyanping, Shenfu injection, cephalosporin for injection, Chinese medicine without decoction, Sanjiuweitai granules, Zhengtian pills, etc.

2. China Resources Tianhe, a subsidiary of the company, produces mask products with the same protective material as N95. This product is more comfortable and is a general protective product.

Zixin Pharmaceutical

The highest number of closed orders: 32.9193 million, the current number of closed plates: 24.7329 million, accounting for 2.48% of the actual circulation, accounting for Volume: 15.38%.

Zixin Pharmaceutical's daily limit is classified as traditional Chinese medicine + industrial hemp

1. The company's main business is Chinese patent medicine industry, ginseng industry, industrial hemp industry. The company's main products are pills, tablets, hard capsules, oral liquids, granules, oral solutions, mixtures, soft capsules, lozenges, ginseng products, and industrial hemp products.

2. The company signed the "Entrustment Agreement" with Beidahuang Kenfeng Seed Industry Co., Ltd., entrusting it to introduce 20kg of industrial hemp seeds named FG230519HJ from the Netherlands to In my country

Jianmin Group

The highest number of sealed orders: 313,500, the current number of sealed plates: 3,900, accounting for 0.00% of the actual circulation , accounting for the day's trading volume: 0.03%.

The reason for the daily limit of Jianmin Group is traditional Chinese medicine + third child

1,The company's main business is the research and development, manufacturing, wholesale and retail of pharmaceuticals. The main products are Longmu Zhuanggu Granules, Jianpi Shengxue Granules/tablets, Xiaojin Capsules, Biantong Capsules, Xiaoer Baotaikang Granules, Children Xuanfei Zhike Granules, Jianwei Xiaoshi Tablets, etc.

2. The company is a national key traditional Chinese medicine enterprise and a production base for pediatric medicine. The company has rich product resources, and has formed a pediatric product line, a gynecological product line, and a characteristic traditional Chinese medicine product line based on proprietary Chinese medicines. Among them, the pediatric product line includes Longmu Zhuanggu Granules, Xiaoer Baotaikang Granules, Xiaoer Xuanfei Zhike Granules, and Xiaoer Jiegan Granules.

Tongrentang

The highest number of closed orders: 8.6189 million, the current number of closed plates: 4.5477 million, accounting for 0.70% of the actual circulation, accounting for the transaction on the day Amount: 23.54%.

Tong Ren Tang's daily limit is classified as traditional Chinese medicine. The company's main business is the research and development, production and sales of traditional Chinese medicine; the company's main products are Angong Niuhuang Pills, Tongren Niuhuang Qingxin Pills, and Tongren Dahuoluo Pills; Tongrentang is a well-known time-honored brand in the Chinese medicine industry; The top ten ace products represented by Niuhuang Qingxin Pill and Tongren Dahuoluo Pill, as well as many classic drugs, are well-known at home and abroad, and enjoy a high reputation in clinical patient treatment. The company's business covers 20 countries and regions.

Xintian Pharmaceutical

The highest number of closed orders: 4.8697 million, the current number of closed plates: 1.1783 million, accounting for 1.25% of the actual circulation, accounting for the current day Volume: 12.55%.

Xintian Pharmaceutical's daily limit is classified as traditional Chinese medicine. The company's main business is the research and development, production and sales of proprietary Chinese medicines. The company's main products are Ningmitai Capsules, Kuntai Capsules, Sophora Gel, and Prunella Oral Liquid. The company adheres to the application of modern scientific and technological concepts and achievements, and relies on the rich resources of Chinese herbal medicines in Guizhou Province to research and develop modern Chinese medicines that are "clear and clear".

Qianjin Pharmaceutical

The highest number of closed orders: 3.1397 million, the current number of closed plates: 75,600, accounting for 0.03% of the actual circulation, accounting for the transaction on the day Amount: 0.17%.

Qianjin Pharmaceutical's daily limit is classified as traditional Chinese medicine. The company is a company that mainly develops, produces and sells Chinese patent medicines. It is one of the top 50 key enterprises in the Chinese patent medicine industry in the country. The products include gynecological Qianjin tablets, Jinshu rheumatism wine, and nourishing blood and Yimu granules. The main products are Chinese medicine production, Chinese herbal medicines and decoction pieces Production, Western medicine production, pharmaceutical wholesale and retail, entertainment, hygiene products.

Xinguang Pharmaceutical

The highest number of closed orders: 16.2762 million, the current number of closed plates: 2.913 million, accounting for 2.95% of the actual circulation, accounting for the transaction on the day Amount: 17.62%.

The reason for Xinguang Pharmaceutical's daily limit is traditional Chinese medicine. The company is mainly engaged in the R&D and production of Chinese patent medicines. At present, it has 52 varieties of 6 dosage forms, and the products are mainly Chinese patent medicine preparations.

Longjin Pharmaceutical

The highest number of sealed orders: 8.7566 million, the current number of sealed plates: 3.7317 million, accounting for 1.61% of the actual circulation , accounting for the day's trading volume: 6.96%.

Longjin Pharmaceutical's daily limit is classified as traditional Chinese medicine

1. The company is engaged in modern traditional Chinese medicine and characteristic chemical generic drugs A pharmaceutical company that develops, manufactures and sells. The company's main product is breviscapine for Longjin injection, which is a high-purity traditional Chinese medicine freeze-dried powder injection. The product has the effects of promoting blood circulation, removing blood stasis, dredging collaterals and relieving pain. It is used for the treatment of cardiovascular and cerebrovascular diseases, mainly for the treatment of stroke and its sequelae. Coronary heart disease, angina pectoris.

2. The company increased the capital of Yunnan Muya Agricultural Technology Co., Ltd. (Muya Agriculture) by RMB 15 million, and obtained 51% of its equity. The main business of Muya Agriculture is the large-scale cultivation of industrial hemp.

Jichuan Pharmaceutical

The highest number of sealed orders: 4.8582 million, the current number of sealed plates: 971,300, accounting for 0.30% of the actual circulation , accounting for the day's trading volume: 2.88%.

The reason for the daily limit of Jichuan Pharmaceutical is traditional Chinese medicine. The company's main business is the research and development, production and sales of drugs. The company's drug product line mainly focuses on pediatrics, digestion, respiration and other fields. Wait.

Jiuzhitang

The company specializes in traditional Chinese medicine and ranks first in China's time-honored enterprises in Hunan Province; it participates in the pharmaceutical unicorn enterprise Kexinmeide.

The main capital net inflow was 66.04 million yuan, up and down 10.04%, and the main net volume (dde large order net/tradable shares) was 0.91%, ranking 96th in the two cities /4601.



Today's main net power is Positive, and the value is relatively large, indicating that the main capital has flowed into the market, and the active buying is obviously more than the active selling. Jiuzhitang rose 10.04% today, and the main force rose significantly.

Zuoli Pharmaceutical

Transactions in Traditional Chinese Medicine Stocks
1. The company's main business is medicinal fungi Wuling and Bailing series products , R&D, production and sales of Chinese herbal decoction pieces and Chinese herbal formula granules. The company's main products include Wuling series and Bailing tablets, Chinese herbal decoction pieces and Chinese herbal formula granules.

2. The company is a modern biotechnology enterprise engaged in the development, production and sales of downstream traditional Chinese medicine products of Wulingshen using fermentation technology. The main product is Wuling Capsule, which belongs to the national A class of new drugs is an exclusive variety listed in the national medical insurance. It has the functions of nourishing the heart and soothing the nerves, nourishing the kidney and strengthening the brain. It is mainly used for the treatment of neurasthenia, anxiety, depression and insomnia.

The net outflow of main funds was 183 million yuan, up and down 13.72%, and the main net volume (net value of dde orders/tradable shares) was -2.85%, ranking the two cities 4589/4601.



Today's main net volume is Negative, and the value is large, indicating that funds have flowed out significantly, and active selling is significantly more than active buying. At the same time, the turnover rate is high today, and the main force is suspected of selling.

Zhongheng Group

The main business is medicine and medical protection Product manufacturing, food manufacturing, Chinese herbal medicine planting, pharmaceutical distribution and daily chemical industry. The main products are Xueshuantong for injection (lyophilized), Zhonghua Dieda Pills, Fuyanjing Capsules, Shishitong Tablets, Yanjianning Tablets, Angong Niuhuang Pills, Shedan Chuanbei Liquid, Fluorescein Sodium Injection, "Shuangqian". ” brand Guiling paste, mouthwash, mouth spray, laundry detergent, laundry beads, electric toothbrush, tooth irrigator, electric toothpaste. Hosted by the China Pharmaceutical Industry Information Center, guided by the Ministry of Industry and Information Technology, and the General Institute of Pharmaceutical Industry Research, and ranked according to the "China Pharmaceutical Statistical Annual Report", the list of the top 100 pharmaceutical industries published by Minet. Its market promotion ability ranks 19th on the top 100 Chinese medicine enterprises in my country.

Panlong Pharmaceutical

Changes in Chinese medicine stocks
1. The company is a collection of standardized planting of medicinal materials, drug production, research and development, sales and pharmaceutical logistics. A modern high-tech enterprise in core industries. The company has 16 production lines such as tablets and capsules that have passed the new national GMP certification, as well as supporting inspection and scientific research equipment. Now it has formed a "national exclusive patent, medical insurance class A" variety, dominated by Panlong seven tablets, covering rheumatism and bone injury. A strong product lineup with more than 100 product specifications in 9 major functional categories, such as electronic products, cardiovascular and cerebrovascular products.

2. The company's leading variety, Panlong Qi Pian, is the national exclusive, medical insurance category A variety, and has been selected as a Chinese medicine protection variety. It consists of twenty-nine Chinese herbal medicines, including thirteen rare and authentic herbs such as Panlong Qi, Zhuangjindan, Guoshanlong, and Zhuzishen, all of which are unique and precious and grow in Qinba Mountains at an altitude of more than 1,800 meters. Chinese herbal medicine. Panlong Qi Pian has strong market competitiveness in the field of traditional Chinese medicine for treating rheumatic diseases of the musculoskeletal system

3. The company's leading product Panlong Qi Pian is used in combination The seven dragons, the seven horns, the seven frogs, the seven mice, the seven white hairs, the seven buttons7. Bamboo root seven and other 29 kinds of characteristic and authentic medicinal materials grown in Qinling Mountains are all precious medicinal materials; the company has planted more than 18,000 mu of medicinal materials such as astragalus and isatidis in Huachi County, Gansu Province, and at the same time built a plant in Zhashui County, Shangluo City Wild tending more than 100,000 mu of Schisandra chinensis industrialization demonstration base and more than 2,000 mu of honeysuckle and other medicinal material planting bases. , the main net volume (dde large single net / outstanding shares) was 1.85%, and the two cities ranked 28/4601.



Panlong Pharmaceutical Today The main net volume is positive, and the value is large, indicating that the main capital has flowed in substantially, and the active buying is significantly more than the active selling. Panlong Pharmaceutical closed up 2.46% today, and the main force may be accumulating and building positions.

Kunning Pharmaceutical Group

Transaction of Chinese Medicine Stocks
A unique natural herbal medicine R&D and production enterprise in China; products are mainly concentrated in the field of cardiovascular and cerebrovascular , Panax notoginseng saponins series are rich in varieties, the core varieties are traditional Chinese medicine injection Luotai injection Xuesaitong and Xuesaitong soft capsule.

The net inflow of the main funds was 105 million yuan, up and down 8.55%, and the main net volume (net amount of dde orders/tradable shares) was 1.26%, ranking 44th in the two cities /4601.



Kun Pharmaceutical Group Today's main net volume is positive, and the value is large, indicating that the main capital has flowed in substantially, and active buying is significantly more than active selling. Kunming Pharmaceutical Group rose 8.55% today, with the main force rising significantly.

Kangyuan Pharmaceutical

Main business is the research and development, production and sales of pharmaceuticals. The company's main products currently include Reduning Injection, Jinzhen Oral Liquid, Xingbei Zhike Granules, Guizhi Fuling Capsules, Sanjie Analgesic Capsules, Ginkgo Diterpene Lactone Meglumine Injection, Tianshu Capsules, and Longxue Tongluo Capsules. , Yixinshu Tablets, Dazhu Hongjingtian Capsules, Cistanche Total Glycosides Capsules, Yaobitong Capsules, Compound Nanxing Pain Relief Cream, Epimedium Total Flavonoids Capsules, Anti-Bone Proliferation Capsules, Jiuwei Xifeng Granules. The company's digital extraction and refining factory was included in the pilot demonstration project of intelligent manufacturing by the Ministry of Industry and Information Technology; the intelligent oral solid preparation factory project of traditional Chinese medicine was selected as the "Excellent Project of Social Responsibility of Chinese Pharmaceutical Enterprises".

Foci Pharmaceuticals

Transactions of Chinese medicine stocks
The company's main business is the research and development, manufacturing and sales of Chinese patent medicines and general health products, Chinese medicine Planting, processing and sales of timber. The company's main products include Liuwei Dihuang Pills, Xiaoyao Pills, Xiangsha Yangwei Pills, Ginseng Guben Huanshao Pills and other series of proprietary Chinese medicines, as well as Ejiao, Ejiao cakes and other large health products.

The main capital net inflow was 73.7180 million yuan, up and down 9.97%, and the main net volume (dde large order net/tradable shares) was 1.44%, ranking 36th in the two cities /4601.



The main force of Foci Pharmaceuticals today The net amount is positive and the value is relatively large, indicating that the main funds have flowed in substantially, and the active buying is significantly more than the active selling. Foci Pharmaceuticals soared 8.37% today, with the main force rising significantly.

Shanghai Kaibao

The main capital net inflow was 75.9159 million yuan, up and down 16.88%. shares) was 1.14%, and the two cities ranked 73/4601.



Shanghai Kaibao’s main net power today is positive and the value If it is larger, it indicates that the main capital has flowed in substantially, and the active buying is obviously more than the active selling. Shanghai Kaibao rose 16.88% today, with the main force rising significantly.

Tus Pharmaceuticals

Transactions of Chinese medicine stocks
The company has established a provincial enterprise technology center, Hunan Province traditional Chinese medicine liquid preparation engineering technology center, etc. The platform continuously cultivates and improves the company's technological innovation capability and scientific research level through various methods such as independent research and development and cooperative development. Company based in HunanThe ancient Han health essence (oral liquid, tablet) developed by the health formula unearthed in Mawangdui has been rated as a national secret technology project variety and a national traditional Chinese medicine protected variety because of its unique formula.

The net inflow of main funds was 23.255 million yuan, up and down 8.40%, and the main net volume (net amount of dde orders/tradable shares) was 0.90%, ranking 98th in the two cities /4601.



Tushold Pharmaceutical Today's main net volume is positive, and the value is large, indicating that the main capital has flowed in substantially, and active buying is significantly more than active selling. TusHoldings rose sharply by 8.40% today, with the main force rising significantly.

Article Url:https://www.liaochihuo.com/info/670326.html

Label group:[drug] [Chinese patent medicine] [traditional Chinese medicine] [circulation plate

Hot topic

Health regimen recommend

Health regimen Popular